Literature DB >> 2237780

Autoradiographic localization of cocaine binding sites by [3H]CFT ([3H]WIN 35,428) in the monkey brain.

D R Canfield1, R D Spealman, M J Kaufman, B K Madras.   

Abstract

The cocaine analog [3H]2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane ([3H]CFT or [3H]WIN 35,428 binds with high affinity and selectivity to cocaine receptors in the monkey caudate-putamen. [3H]CFT was used to map the regional distribution of cocaine binding sites in slide-mounted sections of monkey brains using autoradiographic techniques. Hemicoronal brain sections were incubated with [3H]CFT (3 nM) alone or in the presence of excess (-)-cocaine (30 microM) to mask the binding sites. High densities of [3H]CFT binding sites were detected in the caudate nucleus, putamen, and nucleus accumbens. In all three regions, binding was markedly reduced by coincubation with unlabeled (-)-cocaine, indicating low levels of nonspecific binding. Little or no binding was observed in the cortex, thalamus, globus pallidus, or white matter tracts at the levels studied. In order to characterize binding sites for [3H]CFT in tissue sections, competition experiments were conducted using a fixed concentration of [3H]CFT (3 nM) and a range of concentrations of (-)-cocaine, (+)-cocaine, CFT, Lu 19-005, GBR 12909, bupropion, and citalopram. The IC50 values for the drugs in tissue sections corresponded closely with their reported IC50 values in monkey caudate-putamen membranes (r = 0.99, p less than 0.001), suggesting that [3H]CFT binding is similar in the two preparations. These findings support the view that cocaine receptors labeled by [3H]CFT are localized predominantly in dopamine-rich brain regions implicated in the behavioral effects and abuse of cocaine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2237780     DOI: 10.1002/syn.890060211

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  12 in total

1.  Synthesis and structure-activity relationship studies of 3-biaryl-8-oxabicyclo[3.2.1]octane-2-carboxylic acid methyl esters.

Authors:  Lokman Torun; Bertha K Madras; Peter C Meltzer
Journal:  Bioorg Med Chem       Date:  2012-02-08       Impact factor: 3.641

Review 2.  Brain dopaminergic system changes in drug addiction: a review of positron emission tomography findings.

Authors:  Haifeng Hou; Chunyan Wang; Shaowei Jia; Shu Hu; Mei Tian
Journal:  Neurosci Bull       Date:  2014-09-28       Impact factor: 5.203

3.  Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys.

Authors:  S R Letchworth; M A Nader; H R Smith; D P Friedman; L J Porrino
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

4.  Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations.

Authors:  V Villemagne; J Yuan; D F Wong; R F Dannals; G Hatzidimitriou; W B Mathews; H T Ravert; J Musachio; U D McCann; G A Ricaurte
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

5.  Anhedonia, Reduced Cocaine Reward, and Dopamine Dysfunction in a Rat Model of Posttraumatic Stress Disorder.

Authors:  Nicole M Enman; Kayti Arthur; Sara J Ward; Shane A Perrine; Ellen M Unterwald
Journal:  Biol Psychiatry       Date:  2015-05-06       Impact factor: 13.382

6.  Psychotropic drug-induced locomotor hyperactivity and prepulse inhibition regulation in male and female aromatase knockout (ArKO) mice: role of dopamine D1 and D2 receptors and dopamine transporters.

Authors:  Carolina Chavez; Andrea Gogos; Margaret E Jones; Maarten van den Buuse
Journal:  Psychopharmacology (Berl)       Date:  2009-07-14       Impact factor: 4.530

7.  Abstinence from chronic cocaine self-administration alters striatal dopamine systems in rhesus monkeys.

Authors:  Thomas J R Beveridge; Hilary R Smith; Michael A Nader; Linda J Porrino
Journal:  Neuropsychopharmacology       Date:  2008-09-03       Impact factor: 7.853

8.  Amphetamine-induced release of dopamine in primate prefrontal cortex and striatum: striking differences in magnitude and timecourse.

Authors:  Hank P Jedema; Rajesh Narendran; Charles W Bradberry
Journal:  J Neurochem       Date:  2014-05-19       Impact factor: 5.372

9.  1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.

Authors:  Peter C Meltzer; David Butler; Jeffrey R Deschamps; Bertha K Madras
Journal:  J Med Chem       Date:  2006-02-23       Impact factor: 7.446

10.  Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.

Authors:  U D McCann; D F Wong; F Yokoi; V Villemagne; R F Dannals; G A Ricaurte
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.